Health Atezolizumab Regimen Safe in Resectable Mesothelioma Eli Pacheco Sep 30, 2021 0 Use of atezolizumab (Tecentriq) as part of neoadjuvant therapy and again as maintenance met predetermined…
Health Genentech Pulls Atezolizumab’s Breast Cancer Approval Eli Pacheco Aug 28, 2021 0 Genentech announced that it will voluntarily withdraw its accelerated approval of the PD-L1…
Health Add-On PD-L1 Inhibitor Promising in Muscle-Invasive Bladder Cancer Eli Pacheco Jul 9, 2021 0 Adding the PD-L1 inhibitor atezolizumab (Tecentriq) to standard neoadjuvant therapy with gemcitabine and…
Health No Boost in pCR With Added Atezolizumab in HER2-Positive Early Breast Cancer Eli Pacheco Jun 22, 2021 0 Adding atezolizumab (Tecentriq) to standard of care treatment for patients with high-risk,…